Quantitative analysis for MapLight Therapeutics Inc. Common Stock (MPLT) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Unrated (50.0). 23 signals analyzed (19 differentiated alt-data).
MPLT stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-05-01 | $31.83 | $30.40 | $30.70 |
| 2026-05-13 | $31.34 | $29.44 | $30.67 |
| 2026-05-26 | $29.73 | $28.25 | $29.46 |
| 2026-06-05 | $30.10 | $27.15 | $28.01 |
| 2026-06-17 | $29.56 | $27.21 | $29.21 |
| 2026-06-30 | $37.03 | $33.72 | $35.84 |
| 2026-07-13 | $39.28 | $35.63 | $36.57 |
| 2026-07-23 | $36.03 | $34.49 | $35.23 |
| 2026-08-04 | $13.03 | $12.37 | $12.94 |
| 2026-08-17 | $11.79 | $10.96 | $11.24 |
| 2026-08-27 | $13.24 | $12.49 | $12.54 |
| 2026-09-09 | $14.22 | $13.51 | $13.71 |
How MapLight Therapeutics Inc. Common Stock stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| AZN | AstraZeneca PLC | $290.7B | — |
| NVS | Novartis AG | $287.1B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| SNY | Sanofi | $107.6B | — |
View all Health Care stocks by valuation and signals →
MapLight Therapeutics Inc. Common Stock (MPLT) scores Unrated (50.0), and the composite conceals a 89-point disagreement between its dimensions. It is strongest on ML forecast at 91 and competitive moat at 87, and weakest on technicals at 2. A stock can carry ML forecast that high while technicals sits at 2; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| ML forecast | 91 |
| competitive moat | 87 |
| analyst consensus | 74 |
| technicals | 2 |
StoQuant analyzes 23 signals (19 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on MapLight Therapeutics Inc. Common Stock (MPLT): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/MPLT"><img src="https://stoquant.com/badge/MPLT.svg" alt="MapLight Therapeutics Inc. Common Stock (MPLT) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.